Orpharm is a member of the World Orphan Drug Alliance (WODA).  WODA provides full-service solution to pharmaceutical & biotech companies with a portfolio of rare diseases, oncology and highly specialized therapeutics, starting from named patient programs to full commercialization.   WODA covers 68 countries in the following regions:  – Central and Eastern Europe (Medis) – Latin America (OrphanDC) – Middle East, North Africa & Turkey (Vector Pharma) – Russia & the CIS region (Orpharm) – Switzerland (EffRx Pharmaceuticals)